Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder.
What is new in MS spasticity research? Poster session highlights.
Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
Human endogenous retrovirus-K contributes to motor neuron disease.
Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice.
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis.
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis.
Reliability of Accelerometer Scores for Measuring Sedentary and Physical Activity Behaviors in Persons With Multiple Sclerosis.
Relapses in multiple sclerosis: effects of high-dose steroids on cortical excitability.
Internal jugular vein blood flow in multiple sclerosis patients and matched controls.
Modelling the natural history of primary progressive multiple sclerosis.
Mining gene expression data of multiple sclerosis.
Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course.
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures.
The POLG Polyglutamine Tract Variants in Iranian Patients with Multiple Sclerosis.
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
Neurodegeneration: From Multiple Sclerosis to Alzheimer's Disease.
Neuroimaging assessment of spasticity developed after acquired brain injuries and multiple sclerosis.
8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.
Environmental enrichment and brain repair: Harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticity.
Biochemical Pharmacology of the Sigma-1 Receptor.
Pages
« first
‹ previous
…
548
549
550
551
552
553
554
555
556
…
next ›
last »